About Diaverum
Diaverum is a company based in Munchen (Germany) founded in 2007 was acquired by M42 in April 2023. Diaverum has raised $28.46 million across 3 funding rounds from investors including CPP Investments, Bridgepoint Capital and European Union. Diaverum has completed 1 acquisition, including Advance Renal Care. Diaverum offers products and services including d.CARE App, d.HOLIDAY Program, and Haemodialysis Service. Diaverum operates in a competitive market with competitors including Nierenzentrum Wertheim and Nierenzentrum Tauberbischofsheim, among others.
- Headquarter Munchen, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Diaverum Deutschland Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.46 M (USD)
in 3 rounds
-
Latest Funding Round
$842.63 K (USD), Grant
Jan 01, 2018
-
Investors
CPP Investments
& 4 more
-
Employee Count
Not available
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Diaverum
Diaverum offers a comprehensive portfolio of products and services, including d.CARE App, d.HOLIDAY Program, and Haemodialysis Service.
App empowering patients with chronic kidney disease management tools.
Program facilitating dialysis access for patients traveling internationally.
Treatment removing toxins from blood for kidney failure patients.
People of Diaverum
Unlock access to complete
Funding Insights of Diaverum
Diaverum has successfully raised a total of $28.46M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $842.63 thousand completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Diaverum
Diaverum has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include CPP Investments, Bridgepoint Capital and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed across multiple sectors.
|
Locked | Locked | Locked | |
|
Middle-market businesses up to €1 billion are acquired pan-Europe.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Diaverum
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diaverum
Diaverum has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Advance Renal Care.
Investment portfolio details for Diaverum
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A chain of dialysis clinics is operated in Singapore.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Diaverum
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Diaverum
Detailed financials for Diaverum
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diaverum Comparisons
Peer comparison for Diaverum
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Diaverum
Diaverum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nierenzentrum Wertheim and Nierenzentrum Tauberbischofsheim, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Operates a chain of dialysis clinics providing essential renal care services.
|
|
| Locked | Locked | Locked |
Operates a chain of dialysis clinics providing essential services.
|
Detailed competitors of Diaverum
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diaverum
Complete news archive for Diaverum
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diaverum
Diaverum was founded in 2007.
Diaverum is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Diaverum is a funded company, having raised a total of $28.46M across 3 funding rounds to date.
Diaverum was established in 2007 and is headquartered in Munich, Germany. Operations focus on the healthcare sector, specifically renal care, through a chain of dialysis clinics. Services include hemodialysis and related treatments for patients with kidney conditions. The network spans multiple locations, with emphasis on clinical care and patient management in Europe and beyond. Expansion has been pursued to enhance accessibility in the dialysis field.
Diaverum's top competitors include Nierenzentrum Wertheim and Nierenzentrum Tauberbischofsheim.
Diaverum offers d.CARE App, d.HOLIDAY Program, and Haemodialysis Service.
Diaverum has made 1 acquisition, including Advance Renal Care.
Diaverum has 5 investors. Key investors include CPP Investments, Bridgepoint Capital, European Union, M42, and ATP Private Equity Partners.